VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. by Yoon, Y, Murayama, T, Gravereaux, E, Tkebuchava, T, Silver, M, Curry, C, Wecker, A, Kirchmair, R, Hu, C, Kearney, M, Ashare, A, Jackson, D, Kubo, H, Isner, J, Losordo, D

Nilotinib-induced vasculopathy: Identification of vascular endothelial cells as a primary target site by Hadzijusufovic, E, Albrecht-Schgoer, K, Huber, K, Hoermann, G, Grebien, F, Eisenwort, G, Schgoer, W, Herndlhofer, S, Kaun, C, Theurl, M, Sperr, W, Rix, U, Sadovnik, I, Jilma, B, Schernthaner, G, Wojta, J, Wolf, D, Superti-Furga, G, Kirchmair, R, Valent, P